A3373 is a novel inhibitor targeting both Phospholipase D1 (PLD1) and Phospholipase D2 (PLD2), demonstrating half maximal inhibitory concentrations (IC50) of 325 nM for PLD1 and 15.15µM for PLD2. This compound effectively suppresses lipopolysaccharide (L
Target:
Phospholipase
* VAT and and shipping costs not included. Errors and price changes excepted